Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 46 (N.D.W.Va. Dec. 29, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 46 (N.D.W.Va. Dec. 29, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 33 (N.D.W.Va. Dec. 14, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 33 (N.D.W.Va. Dec. 14, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 524 (N.D.W.Va. Jun. 6, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 524 (N.D.W.Va. Jun. 6, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 525 (N.D.W.Va. Jun. 6, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 525 (N.D.W.Va. Jun. 6, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 516 (N.D.W.Va. May. 31, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 516 (N.D.W.Va. May. 31, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 436 (N.D.W.Va. Apr. 28, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 436 (N.D.W.Va. Apr. 28, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 427 (N.D.W.Va. Apr. 19, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 427 (N.D.W.Va. Apr. 19, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 425 (N.D.W.Va. Apr. 14, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 425 (N.D.W.Va. Apr. 14, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd., 1:23-cv-00106, No. 9 (N.D.W.Va. Dec. 28, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd., 1:23-cv-00106, No. 9 (N.D.W.Va. Dec. 28, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd., 1:23-cv-00106, No. 1 (N.D.W.Va. Dec. 27, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd., 1:23-cv-00106, No. 1 (N.D.W.Va. Dec. 27, 2023)
+ More Snippets
Document
IPR2024-00260, No. 9 Adverse judgment post institution - Adverse judgment post institution (P.T.A.B. Jul. 23, 2024)
Cite Document
IPR2024-00260, No. 9 Adverse judgment post institution - Adverse judgment post institution (P.T.A.B. Jul. 23, 2024)
+ More Snippets
Document
IPR2023-00884, No. 69 Adverse judgment post institution - Adverse judgment post institution (P.T.A.B. Jul. 23, 2024)
Cite Document
IPR2023-00884, No. 69 Adverse judgment post institution - Adverse judgment post institution (P.T.A.B. Jul. 23, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 87 (N.D.W.Va. Oct. 25, 2022)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 87 (N.D.W.Va. Oct. 25, 2022)
+ More Snippets
Document
IPR2023-00884, No. 65 Order Other - Order Granting Patent Owner’s Unopposed Motion for Entry of Amended Protective Order (P.T.A.B. Jun. 11, 2024)
Cite Document
IPR2023-00884, No. 65 Order Other - Order Granting Patent Owner’s Unopposed Motion for Entry of Amended Protective Order (P.T.A.B. Jun. 11, 2024)
+ More Snippets
Document
IPR2023-00884, No. 58 Order on Motion - ORDER Granting Petitioner’s Motion for Additional Discovery 37 CFR § 4251b2 (P.T.A.B. May. 23, 2024)
Cite Document
IPR2023-00884, No. 58 Order on Motion - ORDER Granting Petitioner’s Motion for Additional Discovery 37 CFR § 4251b2 (P.T.A.B. May. 23, 2024)
+ More Snippets